Drug factory · FDA FEI 3004485164

Sterling Wisconsin, LLC

W132n10550 Grant Dr, Germantown, WI, United States

United States: 1

No problems found at FDA's last inspection, Mar 12, 2024.

No Action Indicated: inspectors found no objectionable conditions.

12 drug inspections on record since 2009: 2 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Nitrite Ion and Thiosulfate IonMakes the active ingredient Hope Pharmaceuticals 60267-812
Thiosulfate IonMakes the active ingredient Hope Pharmaceuticals 60267-705

FDA inspection history

EndedResultProgramProblems noted
Mar 12, 2024No problems foundDrug Quality Assurance—
Mar 12, 2024No problems foundDrug Quality Assurance—
Jun 24, 2016No problems foundDrug Quality Assurance—
Jun 24, 2016No problems foundDrug Quality Assurance—
Sep 18, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Sep 18, 2013Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 16, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 16, 2011Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 4, 2009Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 4, 2009Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 4, 2009Problems found, fixed voluntarilyDrug Quality Assurance—
Aug 4, 2009Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; particle size reduction.